COR:NYSE
Cencora Inc
$326.23
arrow_upward
+1.45%(+4.66) 1D
$326.23
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 14, 4:00:08 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
$325.64
High
$327.79
Low
$322.46
Mkt. cap
14.42B
Avg. vol.
1.41M
Volume
1.06M
52-wk high
$377.54
52-wk low
$244.82
Beta
0.57
Shares outstanding
190.83M
No. of employees
49K
Open
$325.64
High
$327.79
Low
$322.46
Mkt. cap
14.42B
Avg. vol.
1.41M
Volume
1.06M
52-wk high
$377.54
52-wk low
$244.82
Beta
0.57
Shares outstanding
190.83M
No. of employees
49K
News stories
From web sources and news partners
Simply Wall Street
·
47 minutes ago
Cell Therapy Support Launch Could Matter For Cencora Stock (COR)
News Corp
·
4 hours ago
Cencora Inc. stock outperforms competitors on strong trading day
Kalkine Media
·
12 hours ago
Why Does Cencora (NYSE:COR) Stand Out Among S&P 500 Healthcare Stocks?
ChartMill
·
17 hours ago
Cencora (NYSE:COR): A Quality Stock With Strong EBIT Growth and Cash Conversion
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc